Watch Demo

Italy Cardiovascular Drug Industry Outlook 2022 - 2026

See how Italy Cardiovascular Drug performed compared to key markets such as Germany and Canada.

Key Market Indicators

Sales of beta-blocking medicines in Italy are set to reach €420 million (rounded to €400 million) by 2026. This would mark a growth of 0.8% year on year, according to a new report. Since 2016, the Italian market has grown by 3.8% year on year. In 2021, Germany overtook Italy, with sales of €457.93 million (rounded to €460 million). Italy, Canada and Australia were ranked second, third and fourth respectively.

Marketing Banner

Italy Cardiovascular Drug Market Data and Forecasts

How much will Italy Cardiovascular Drug Market grow to 2026?

Forecast: Antiarrhythmic Medicine Sales in Italy
Forecast: Calcium Channel Blocking Medicine Sales in Italy
Forecast: Cardiovascular System Medicine Sales in Italy
Forecast: Beta Blocking Medicine Sales in Italy
Forecast: Diuretic Medicine Sales in Italy
More in Cardiovascular Drug Industry for 2028

Improve your Knowledge with the latest Indicators and Trends